🔎 Trials Near Me

Pradžia › Psichikos sutrikimai › Texas

Psichikos sutrikimai klinikiniai tyrimai Texas

7 tyrimai dėl Psichikos sutrikimai ieško dalyvių vietose Texas.

Miestai Texas

Oficialus tyrimo tekstas (anglų kalba)

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

  • Austin, Texas, Austin
  • Dallas, Texas, Dallas
  • Houston, Texas, Houston
  • ir dar 2
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07598708

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Austin
  • Clinical Site, McKinney
  • Clinical Site, Sugarland
Renkami dalyviai2 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06887192

Successful Transitions and Reintegration Tools for Veterans (START-VETS)

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT04366531

Targeted Plasticity Therapy for PTSD

  • The University of Texas Health Austin Ambulatory Surgery Center, Austin
  • Baylor University Medical Center, Dallas
  • Texas Biomedical Device Center, Richardson
Renkami dalyviai
Amžius nuo 22 iki 79 · Visoms lytims · Atnaujinta 2026-09-16 · NCT06266364

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Austin
  • Clinical Site, DeSoto
  • Clinical Site, Richardson
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07459647

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Biobehavioral Research of Austin, Austin
  • InSite Clinical Research, DeSoto
  • Aim Trials, LLC, Plano
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-11 · NCT06524830

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Houston
Renkami dalyviai2 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-02-02 · NCT07105709

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.